ArticleNeuromuscular disorders : NMD2022

Early safety and tolerability profile of the BNT162b2 COVID-19 vaccine in myasthenia gravis.

Itay Lotan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.